Suprachoroidal Triamcinolone Injection for the Management of Chronic Uveitis‐Associated Ocular Hypotony
Open Access
- 1 January 2026
- journal article
- case report
- Published by Wiley in Case Reports in Ophthalmological Medicine
- Vol. 2026 (1) , 2476023
Abstract
Purpose: This study is aimed at describing the use of suprachoroidal triamcinolone injection for the treatment of refractory uveitis‐associated ocular hypotony presumed secondary to ciliary body shutdown. Methods: We report a case of a 58‐year‐old woman with a 26‐year history of idiopathic, noninfectious bilateral panuveitis complicated by recurrent cystoid macular edema and a steroid‐induced ocular hypertension. After treatment with an intravitreal dexamethasone implant and an Ahmed glaucoma valve, she developed persistent hypotony in the right eye with intraocular pressure (IOP) of 2–4 mmHg despite controlled inflammation. Evaluation with gonioscopy and ultrasound biomicroscopy revealed no cyclodialysis cleft or cyclitic membranes. Prior treatments, including topical steroids, repeat dexamethasone implant, Ahmed valve revision, and serial anterior chamber viscoelastic injections, produced only transient improvement. Suprachoroidal triamcinolone (40 mg) was administered. Results: Before injection, IOP ranged from 2 to 6 mmHg. Following treatment, IOP remained ≥ 6 mmHg for approximately 2 months. Best corrected visual acuity improved from 20/80 to 20/50, and additional viscoelastic injections were not required during this period. Numerical hypotony recurred 8 months later. Conclusion: Suprachoroidal triamcinolone may represent a targeted treatment for refractory uveitis‐associated hypotony when ciliary body dysfunction is suspected and other steroid delivery routes are limited. Further study is needed to evaluate durability and broader applicability.Keywords
This publication has 14 references indexed in Scilit:
- Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular EdemaOphthalmology, 2019
- Steroid-induced Glaucoma: An Avoidable Irreversible Blindness2017
- Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein OcclusionJAMA Ophthalmology, 2015
- Risk of Elevated Intraocular Pressure and Glaucoma in Patients with UveitisOphthalmology, 2013
- Hypotony in Patients with Uveitis: The Multicenter Uveitis Steroid Treatment (MUST) TrialOcular Immunology and Inflammation, 2012
- Ocular Inflammation in Behçet Disease: Incidence of Ocular Complications and of Loss of Visual AcuityAmerican Journal of Ophthalmology, 2008
- Topical Ibopamine in the Treatment of Chronic Ocular Hypotony Attributable to Vitreoretinal Surgery, Uveitis, or Penetrating TraumaAmerican Journal of Ophthalmology, 2006
- Chronic prephthisical ocular hypotony treated by intravitreal triamcinolone acetonideActa Ophthalmologica Scandinavica, 2004
- The surgical management of chronic hypotony due to uveitisEye, 2004
- Corticosteroids and Glaucoma RiskDrugs & Aging, 1999